Chemed (NYSE:CHE) EVP Sells $541,040.00 in Stock

Chemed Corporation (NYSE:CHE) EVP Spencer Lee sold 1,000 shares of Chemed stock in a transaction on Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the sale, the executive vice president directly owned 13,912 shares in the company, valued at $7,526,948.48. This trade represents a 6.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Chemed Stock Up 0.8%

Shares of Chemed stock opened at $548.27 on Thursday. The business has a 50-day moving average of $506.04 and a 200-day moving average of $448.64. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The company has a market capitalization of $7.17 billion, a PE ratio of 27.54, a P/E/G ratio of 2.06 and a beta of 0.51. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $557.00.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. During the same quarter in the previous year, the firm posted $4.27 earnings per share. The company’s revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities analysts forecast that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be given a dividend of $0.70 per share. The ex-dividend date of this dividend is Monday, August 17th. This is an increase from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s dividend payout ratio is 14.06%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on CHE shares. Oppenheimer increased their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. Royal Bank Of Canada lifted their price target on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Finally, Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $530.75.

Institutional Trading of Chemed

Several institutional investors have recently added to or reduced their stakes in CHE. Monetary Solutions Ltd acquired a new position in shares of Chemed in the 4th quarter valued at about $25,000. Los Angeles Capital Management LLC acquired a new stake in Chemed during the fourth quarter worth about $26,000. BOK Financial Private Wealth Inc. bought a new position in Chemed in the fourth quarter worth about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Chemed in the second quarter worth about $34,000. Finally, Versant Capital Management Inc boosted its stake in Chemed by 7,500.0% in the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after acquiring an additional 75 shares during the period. Institutional investors own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.